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In this issue of the Biomedical Journal, we learn how bacteria and parasites alike counteract
inflammatory signaling by manipulating purinergic signaling. We also focus on an original
article shedding light on the role of an EpsteineBarr virus encoded gene in metastasis in
nasopharyngeal carcinoma. Finally, we learn about a possible link between Trichomonas
vaginalis and recurrent urinary tract infection.Spotlight on reviews In the extracellular neighborhood, ATP is an importantPerturbing purinergic signaling: a pathogen’s guidebook to
counteracting inflammatory responses
Best known as the universal currency of energy, the nucleo-
tide triphosphate, ATP, powers every living organism on this
planet known to human kind. Yet, outside the cell, ATP and its
derivatives, take on an important role in inflammatory
signaling, capable of controlling the fate of infected cells and
the strength of inflammatory responses. It should thus come
as no surprise that many human pathogens are able to
manipulate this signaling pathway to their advantage. This
issue of the Biomedical Journal includes three reviews
describing the evasive tactics of three of such pathogens,
Trichomonas vaginalis [1], Leishmania [2] and Porphyromonas
gingivalis [3].g Gung University.
ublishing services by Else
s/by-nc-nd/4.0/).signaling molecule that is recognized by purinergic P2 re-
ceptors, divided into P2Y G-protein coupled receptors and P2X
nucleotide-gated ion channels. Intracellular ATP is liberated
as cells die, but its release can also occur in a controlled
manner during cellular stress through pannexins and con-
nexin channels [4,5]. Thus, extracellular ATP constitutes a
danger signal that stimulates the immune system to mount
an inflammatory response (mostlymediated through the P2X7
receptor [6]) and acts as a molecular flare to attract macro-
phages and neutrophils to apoptotic cells [7].
To terminate P2 signaling and return to status quo,
ATP is broken down by widely expressed extracellular
enzymes. The most important of these in immune cells
are the ecto-NTPDase CD39, which breaks ATP down into
ADP and subsequently to AMP, and the ecto-50 nucleo-
tidase CD73, which converts AMP into adenosine [8].
Extracellular adenosine binds to P1 receptors, whichvier B.V. This is an open access article under the CC BY-NC-ND
b i om e d i c a l j o u r n a l 3 9 ( 2 0 1 6 ) 2 2 9e2 3 3230counteract the inflammatory responses elicited by ATP
[9]. Thus, the strength of the inflammatory response de-
pends on the balance between extracellular ATP and
adenosine.
To tip the scales in favor of adenosine, several patho-
gens express enzymes capable of breaking down ATP. The
protozoan parasites T. vaginalis and Leishmania are just two
examples. T. vaginalis causes Trichomoniasis, a sexually-
transmitted infection (STI) that facilitates the trans-
mission of other STIs [10], has a negative impact on
pregnancy outcome [11], and increases the risk of cervical
cancer [12]. With 80% of cases going undetected, Tricho-
moniasis is a major public health problem [13]. Tasca and
her team recently showed that T. vaginalis expresses five
putative ecto-NTPDases [14]. It is thought that the
expression of these enzymes favors the accumulation of
extracellular adenosine. By binding to the A2A receptor,
adenosine inhibits neutrophils from secreting nitric
oxide products that are cytotoxic to T. vaginalis [15]. In
Leishmania, the expression of ATP-hydrolyzing enzymes
has been directly linked with virulence [16]. This parasite,
which is transmitted by the bit of infected sandflies and
causes 300,000 cases of Leishmaniasis each year, cannot
synthesize purine rings and hence expresses ecto-nucleo-
tidases as part of a purine salvaging pathway [17]. In the
case of this intracellular parasite, it is an advantage to be
able to prevent or delay apoptosis of host cells by
degrading extracellular ATP.Fig. 1 e Several pathogens express ecto-nucleotidases (E-NTPDas
the accumulation of extracellular adenosine. This in turn inhibit
through P1 receptors, leading to the evasion of immune response
Almeida da Silva et al., see reference [3] for more details.Another intracellular pathogen, Porphyromonas gingivalis
(P. gingivalis), also impairs ATP-mediated apoptosis by
secreting an ATP-hydrolyzing enzyme [18]. This oral path-
ogen also inhibits the secretion of IL-1b by macrophages in
a P2X7-dependent manner [19]. Besides influencing im-
mune cells, modulation of ATP/adenosine levels may also
promote infection by P. gingivalis effects on the dental
epithelium. Indeed, recent work shows that gingival
epithelial cells (GECs) express adenosine receptors, and that
stimulation of the A2A receptor enhances the proliferation
of P. gingivalis [20].
Thus, these pathogens promote their survival by having
antagonistic effects on P1 and P2 receptors [Fig. 1]. Hence, this
work identifies clear pharmacological targets for therapeutic
studies, which should be relevant not only for awhole range of
infections but also for the treatment of inflammatory
disorders.Spotlight on original articles
Viral gene bypasses immune system to induce metastasis in
head and neck cancer
Nasopharyngeal carcinoma (NPC) is a type of head and neck
cancer, which although rare, is notoriously metastatic.
Although the exact causes of the disease are unknown, it has
been strongly linked to infection with EpsteineBarr viruses) which reduce extracellular levels of ATP while promoting
s signaling through P2 receptors and promotes signaling
s and pathogen survival. Figure kindly provided by Coutinho
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shed light on its aggressive tendency and the role of EBV-
encoded proteins.
EBV is a household name among cell biologists, known
widely as the virus capable of transforming the humble B cell
into an ever propagating immortalized lymphoblastoid cell
line. In the human body however, EBV is usually a harmless
passenger residing in the B cells of around 90% of the popula-
tion worldwide [22]. Yet, under some circumstances, EBV may
create favorable conditions for the development of certain
cancers, notably lymphoma but also NPC, a disease which is
particularly endemic in Southern China and Taiwan [23].
Latent membrane protein 1 (LMP1) is the primary trans-
forming gene product of EBV and has been linked with NPC
[24]. LMP1 is a transmembrane protein that mimics the TNFR
familymember CD40, and activates several signaling pathways
promoting morphological and phenotypic alterations epithe-
lial cells [25]. A key and deadly property however of LMP1 in the
pathogenesis of NCP is its ability to promotemetastasis. TheN-
LMP1 variant, which was isolated from Taiwanese patients
with NPC [26], downregulates the expression of cell adhesion
molecules while upregulating that of matrix metalloproteases
[27,28]. However, little is known about the dynamics of LMP1-
driven metastasis and whether LMP1 alone is sufficient to
drive metastasis in immunocompetent hosts.
To examine the metastatic potential of LMP1, Chang and
colleaguesusedtheirpreviouslydevelopedmodelofEBV-driven
NPC inwhich tumor formation is induced inBALB/cmiceby3T3
cells expressing N-LMP1 [29]. Using PCR, they detected N-LMP1
DNA in the draining lymph nodes of mice as early as 7 days
following tumor formation. To followmetastasis in real time in
living animals, they used a bioluminescent assay in which N-
LMP1 was coupled to a luciferase reporter gene. Luciferase ac-
tivity was detected primarily in the lungs, surprisingly, even
before the rapid growth of the primary tumor.
These results not only show that oncogenic LMP1 alone is
capable of inducingmetastasis in an immunocompetent host,
they also strongly suggest that systemic cancer cell dissemi-
nation is an early event, that can occur before aggressive
growth at the primary site. Thus, early treatment with LMP1-
based therapies will be essential to stop the expansion and
spread of NPC tumors.Also in this issue:
Original articles
Neurotrophic factor linked to bipolar mania
Brain-derived neurotrophic factor (BDNF) is the most abun-
dant growth factor in the central nervous system and is
essential for brain development and plasticity. Imbalance in
BDNF levels e which can be measured directly in the blood
since BDNF crosses freely the bloodebrain barrier e has been
linked to several neuropsychiatric disorders [30], in particular
bipolar disorder, although not all studies have been conclusive
[31] and many have failed to analyze patients according to
mood state (mania, depressive, euthymic). Lin et al. [32]
measure serum BDNF protein and mRNA levels in 30 pa-
tients with bipolar mania and 30 healthy controls. Theirfindings suggest that BDNF levels are low patients with bipolar
mania, although a larger sample size is needed to confirm
these findings.
Visualizing cellular changes in patients with coronary heart
disease
Ischemic heart disease (IHD, also called coronary heart dis-
ease) is the leading cause of mortality worldwide, accounting
for 12.7% of deaths in 2008 [33]. Despite the major burden of
the disease, the damage that occurs to the myocardium on a
cellular level mostly been studied in animal models or post-
mortum. Abuderman et al. [34] use light and electron micro-
scopy on biopsies taken from 75 patients undergoing coronary
bypass surgery to study the morphological changes occurring
in vivo during the disease in humans. Fortunately, their find-
ings are consistent with those in animals, including increased
vascular density and increased arteriole wall to lumen ratio in
patients with IHD.
Unassisted central venous catheterization: safe in most cases
but not ideal
Central venous catheterization (central line placement) is a
time-honored technique that is essential for the treatment of
many hospitalized patients. Nowadays, it is normally per-
formed under ultrasound guidance to reduce the risk of
complications. However, in developing countries point-of-
care ultrasound may not be available and the line must be
placed unassisted. To investigate the safety of this approach,
Rathi et al. [35] analyzed 233 attempts at unassisted internal
jugular vein catheterization in patients undergoing hemodi-
alysis at their center in India. Unassisted catheterization was
associated with a slightly higher complication rate than that
typical of ultrasound-guided catheterization, but long term
outcomes were comparable; thus, this alternative method is
acceptable, but only if imaging is not available.
Possible link between parasite and recurrent urinary tract
infection
The protozoan parasite Trichomonas vaginalis (TV) causes the
most common non-viral sexually-transmitted infection in
women, and potentially the most neglected, with 80% of
cases being asymptomatic [13]. Its prevalence is highest
among women in their 50s [36], which incidentally coincides
with the prevalence of another less inconspicuous condition,
recurrent urinary tract infection (UTI) [37]. Noting this
curious trend, Chang et al. [38] investigated the prevalence of
TV in Taiwanese womenwith recurrent UTI. In total, 16.9% of
the 65 women studied had TV. This prevalence is two to eight
times higher than that reported in other populations, sug-
gesting that patients with recurrent UTIs are at risk of TV
infections.
Brief communication
An unusual case of gout
Wu et al. [39] report a rare case of gout affecting the nasal
region and leading to nasal obstruction and bone destruction.
This case highlights the importance of taking a detailed
medical history, especially since gout can mimic malignancy,
unrelated diseases and infection.
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